Abstract:We present an unusual case of a patient with bilateral-lung transplantation due to severe coronavirus disease 2019 (COVID-19), who subsequently suffered complications with acute myocardial infarction and underwent primary percutaneous coronary intervention (PCI). A 70-year-old man presented with fever, cough, and dyspnea after returning from Hubei Province at the end of Jan. 2020. The diagnosis of COVID-19 had been confirmed by the nucleic acid test at a local hospital on Feb. 2, 2020. He had a history of mild hypertension and Type 2 diabetes without regular medication. He was a current smoker but denied the history of ischemic heart disease or hyperlipidemia. Despite initial treatment with methylprednisolone, umifenovir, and darunavir, the patient’s condition worsened with continued dyspnea and persisting fever. On Feb. 9 (Day 7 after symptoms onset), the patient was transferred to the intensive care unit (ICU) of our hospital. On arrival, the patient’s vital signs were stable except for tachypnoea at 27 min. Key laboratory results were: white blood cell count, 6.6×10 L; neutrophil, 89.1%; hemoglobin, 129 g/L; platelet count, 180×10 L; creatinine, 64 μmol/L; high sensitive C reaction protein (hs-CRP), 45.51 mg/L. chest computed tomography (CT) scan showed bilateral diffuse infiltration. After admission, he was treated with high-flow nasal oxygen, methylprednisolone, umifenovir, piperacillin, and tazobactam. On Feb. 14 (Day 12), he was intubated due to severe hypoxia. On Feb. 22 (Day 20), repeated nucleic acid tests for 2019 novel coronavirus (2019-nCoV) in sputum and bronchoalveolar lavage fluid were all negative; however, his condition continued to deteriorate due to pulmonary consolidation complicated by Stenotrophomonas maltophilia infection. We began venovenous extracorporeal membrane oxygenation (ECMO) treatment on Feb. 26 (Day 24). A CT scan on Mar. 2 (Day 29) revealed significant progression of pulmonary consolidation (Fig. 1). A bilateral-lung transplantation was performed on Mar. 8 (Day 34) after multidisciplinary discussion. Postoperatively, the ECMO was withdrawn since the oxygenation had been improved and the patient’s general condition was more stable. A continuous renal replacement therapy (CRRT) was started on Mar. 10 (Day 36/Day 2 postoperative) to support renal function. On Mar. 11 (Day 3 postoperative), laboratory results were: hemoglobin, 80 g/L; platelet count, 36×10 L; creatinine, 103 μmol/L; international normalized ratio (INR), 1.77; activated partial thromboplastin time (APTT), 45.9 s; prothrombin time (PT), 20.8 s; D-dimer, 2927.00 μg/L. On Mar. 12 at 9:00 a.m. (Day 4 postoperative), the patient developed a sudden episode of ventricular fibrillation. After cardiopulmonary resuscitation with Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology) ISSN 1673-1581 (Print); ISSN 1862-1783 (Online) www.jzus.zju.edu.cn; www.springerlink.com E-mail: jzus@zju.edu.cn

Toxic epidermal necrolysis following heart transplantation may caused by cefoperazone sodium and sulbactam sodium

Primary Percutaneous Coronary Intervention in a COVID-19 Patient with ST-segment Elevation Myocardial Infarction after Lung Transplantation: a Case Report

The characters of infections after heart transplantation: prevention and management

The Double-Edged Sword of Immunosuppressive Therapy in Kidney Transplantation: A Rare Case Report of Pulmonary Mucormycosis Post-Transplant and Literature Review

Cancer Immunotherapy and Toxic Epidermal Necrolysis

[Infection after Cardiac Transplantation: Prevention and Management].

Autologous scalp skin grafting to treat toxic epidermal necrolysis in a patient with a large skin injury: A case report

Diagnostic and therapeutic dilemma in Stevens–Johnson syndrome-like acute graft-versus-host disease after liver transplantation: A case report

Pneumocystis Jiroveci Pneumonia in Patients with Toxic Epidermal Necrolysis

The therapy of opportunistic infection after perioperationin heart transplantation (HTx)

Clinical Analysis of Toxic Epidermal Necrolysis after Allogenic Peripheral Blood Stem Cell Transplantation

Effect of basiliximab use on the risk of postoperative infection and death after heart transplantation: An observational study

Care for the organ transplant recipient on the intensive care unit

Tumor necrosis factor-α inhibitor for successful treatment of toxic epidermal necrolysis with severe infection: a case series

Sepsis Resulting from Enterobacter Aerogenes Resistant to Carbapenems after Liver Transplantation.

Toxic epidermal necrolysis in hepatitis A infection with acute-on-chronic liver failure: Case report and literature review

One case of severe pneumocystis carinii pneumonia after renal transplantation

Septic shock after liver transplantation successfully treated with endotoxin and cytokine adsorption continuous renal replacement therapy: a case report and literature review

Prevention and treatment of short-term complications in 8 heart transplantations and 1 heart lung transplantation

An aggressive systematic strategy for acute respiratory distress syndrome caused by severe pneumonia after renal transplantation.

Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation